UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study

Journal of thrombosis and haemostasis, 2017-06, Vol.15 (6), p.1180-1190

2017

Volltextzugriff (PDF)

The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban

Journal of thrombosis and haemostasis, 2018-08, Vol.16 (8), p.1626-1631

2018

Volltextzugriff (PDF)

Frequent False-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin

International journal of laboratory hematology, 2014-04, Vol.36 (2), p.144-150

2014

Volltextzugriff (PDF)

The haemostasis traffic light: a pragmatic tool for bleeding management

Anaesthesia, 2019-12, Vol.74 (12), p.1623-1624

2019

Volltextzugriff (PDF)

Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report

Transfusion and apheresis science, 2021-10, Vol.60 (5), p.103176-103176, Article 103176

2021

Volltextzugriff (PDF)

Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?

International journal of laboratory hematology, 2015-12, Vol.37 (6), p.853-860

2015

Volltextzugriff (PDF)

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain

Journal of thrombosis and haemostasis, 2018-01, Vol.16 (1), p.142-149

2018

Volltextzugriff (PDF)

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1231-1238

2005

Volltextzugriff (PDF)

False‐positive lupus anticoagulant results by DRVVT in the presence of rivaroxaban even at low plasma concentrations

International journal of laboratory hematology, 2018-10, Vol.40 (5), p.e99-e101

2018

Volltextzugriff (PDF)

Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome

Lupus, 2008-10, Vol.17 (10), p.872-877

2008

Volltextzugriff (PDF)

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies

Lupus, 2005, Vol.14 (2), p.129-136

2005

Volltextzugriff (PDF)

Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests

Mediterranean journal of hematology and infectious diseases, 2016-08, Vol.8 (1), p.e2016037-e2016037

2016

Volltextzugriff (PDF)

Anti‐β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model

Journal of thrombosis and haemostasis, 2011-04, Vol.9 (4), p.859-861

2011

Volltextzugriff (PDF)

Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z‐dependent protease inhibitor

Journal of thrombosis and haemostasis, 2003-08, Vol.1 (8), p.1764-1770

2003

Volltextzugriff (PDF)

High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.718-724

2003

Volltextzugriff (PDF)

PB1111 Lupus Anticoagulant Diagnosis: Real Life Rate of Interferences Due to Anticoagulant Treatment in a Laboratory of a High Complexity Hospital

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101014, Article 101014

2023

Volltextzugriff (PDF)

New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests

International journal of laboratory hematology, 2012-04, Vol.34 (2), p.208-213

2012

Volltextzugriff (PDF)

Anti β2 glycoprotein I antibodies: detection and association with thrombosis

British journal of haematology, 1995-02, Vol.89 (2), p.397-402

1995

Volltextzugriff (PDF)

PB1159 Critical Values in Hemostasis Laboratory. Analysis in a 3 Years Period Including Pandemics

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100963, Article 100963

2023

Volltextzugriff (PDF)

Evaluación de la hemostasia y heparinización de pacientes neonatos menores a 5 kg de peso sometidos a cirugía cardiovascular con pruebas viscoelásticas y pruebas de coagulación convencionales

Hematología (En línea), 2023, Vol.27 (3), p.46-56

2023

Volltextzugriff (PDF)

Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation

Thrombosis and haemostasis, 1993, Vol.70 (4), p.667-671

1993

Volltextzugriff (PDF)

Thrombophilic factors in chronic thromboembolic pulmonary hypertension

Blood coagulation & fibrinolysis, 2001-09, Vol.12 (6), p.427-432

2001

Volltextzugriff (PDF)

Evaluación de la hemostasia y heparinización de pacientes neonatos menores a 5 kg de peso sometidos a cirugía cardiovascular con pruebas viscoelásticas y pruebas de coagulación convencionales

Hematología (En línea), 2024-01, Vol.27 (3)

2024

Volltextzugriff (PDF)

PO40 Hyperfiltration Syndrome as a Cause of Low Anti-Xa Activity Levels during Enoxaparin Treatment in a Critically Ill Patient

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.102005, Article 102005

2023

Volltextzugriff (PDF)

PB1234 Prevalence of Studies with Acquired von Willebrand Syndrome Laboratory Profile at the Hospital Italiano de Buenos Aires (HIBA)

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101048, Article 101048

2023

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(93)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(59)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Male
(41)
Female
(40)
Adult
(36)
Hematology
(31)
Middle Aged
(28)
Biological And Medical Sciences
(27)
Medical Sciences
(22)
Cardiovascular System & Cardiology
(18)
Peripheral Vascular Disease
(18)
Aged
(16)
Antiphospholipid Syndrome
(16)
Antibodies, Antiphospholipid - Blood
(15)
Adolescent
(14)
Beta 2-Glycoprotein I
(14)
Glycoproteins - Immunology
(13)
Antiphospholipid Syndrome - Immunology
(12)
Antiphospholipid Antibodies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study

The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban

Frequent False-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin

The haemostasis traffic light: a pragmatic tool for bleeding management

Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report

Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

False‐positive lupus anticoagulant results by DRVVT in the presence of rivaroxaban even at low plasma concentrations

Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome

Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies

Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests

Anti‐β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model

Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z‐dependent protease inhibitor

High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome

PB1111 Lupus Anticoagulant Diagnosis: Real Life Rate of Interferences Due to Anticoagulant Treatment in a Laboratory of a High Complexity Hospital

New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests

Anti β2 glycoprotein I antibodies: detection and association with thrombosis

PB1159 Critical Values in Hemostasis Laboratory. Analysis in a 3 Years Period Including Pandemics

Evaluación de la hemostasia y heparinización de pacientes neonatos menores a 5 kg de peso sometidos a cirugía cardiovascular con pruebas viscoelásticas y pruebas de coagulación convencionales

Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation

Thrombophilic factors in chronic thromboembolic pulmonary hypertension

Evaluación de la hemostasia y heparinización de pacientes neonatos menores a 5 kg de peso sometidos a cirugía cardiovascular con pruebas viscoelásticas y pruebas de coagulación convencionales

PO40 Hyperfiltration Syndrome as a Cause of Low Anti-Xa Activity Levels during Enoxaparin Treatment in a Critically Ill Patient

PB1234 Prevalence of Studies with Acquired von Willebrand Syndrome Laboratory Profile at the Hospital Italiano de Buenos Aires (HIBA)

Suchergebnisse filtern